PRESS RELEASE published on 03/07/2025 at 16:51, 1 year ago EQS-Adhoc: TTL Beteiligungs- und Grundbesitz-AG: Bondholder meeting decides on prolongation of bearer bond 2021/24 (ISIN DE000A3MQAF2; WKN: A3MQAF) TTL Beteiligungs- und Grundbesitz-AG's bondholder meeting approves prolongation of bearer bond 2021/24 with annual repayment and 2.75% p.a. interest rate Bond Conditions TTL Beteiligungs-AG Bearer Bond Prolongation Financial Meeting EUR 10.5 Million
PRESS RELEASE published on 03/07/2025 at 16:34, 1 year ago EQS-Adhoc: KHD Humboldt Wedag International AG: KHD wins major project in India KHD Humboldt Wedag International AG's subsidiary wins a major project in India worth over €100 million for a new cement plant with 10,000 tons per day capacity Contract India KHD Humboldt Wedag Cement Plant €100 Million
PRESS RELEASE published on 03/07/2025 at 16:30, 1 year ago Viromed Medical AG: Strategic healthcare investor acquires further shares in private placement Strategic healthcare investor acquires further shares in Viromed Medical AG through private placement. Majority shareholder Uwe Perbandt reallocates 900,000 shares. Investor now holds 10.62% shares Private Placement Shareholder Strategic Investor Viromed Medical AG Healthcare Investor
PRESS RELEASE published on 03/07/2025 at 16:27, 1 year ago CLINUVEL: Record Half-Year Confirms Growth Trajectory – PARMANTIER & CIE. Presents Latest Research Study on CLINUVEL Pharmaceuticals' Half-Year Results CLINUVEL Pharmaceuticals Ltd. reports record-breaking figures for H1 of fiscal year 2025, surpassing market expectations with strong revenue and EPS growth. Dr. Philippe Wolgen's leadership and strategic foresight driving sustainable success Revenue Increase CLINUVEL Pharmaceuticals Record-breaking Figures Dr. Philippe Wolgen Strategic Foresight
PRESS RELEASE published on 03/07/2025 at 16:23, 1 year ago EQS-Adhoc: NORMA Group SE: Management Board approves guidance for the 2025 financial year NORMA Group SE Management Board approves guidance for 2025 financial year amidst uncertainties, deviating from market expectations. Full outlook in Annual Report 2024 Management Board Guidance Market Expectations NORMA Group SE 2025 Financial Year
PRESS RELEASE published on 03/07/2025 at 16:21, 1 year ago Original-Research: CLINUVEL Pharmaceuticals (von Parmantier & Cie. GmbH): BUY CLINUVEL Pharmaceuticals demonstrates impressive H1/FY25 results, increasing revenue and EPS. New strategy focuses on vitiligo treatment, leading in science-based cosmetic products Investment Recommendation CLINUVEL Pharmaceuticals H1/FY25 Results Vitiligo Treatment Cosmetic Products
PRESS RELEASE published on 03/07/2025 at 15:30, 1 year ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 13.69% interest in American Axle & Manufacturing Holdings, Inc. through Form 8.3. Delivered on 06 March 2025 Securities Form 8.3 Disclosure Vanguard Group American Axle & Manufacturing
PRESS RELEASE published on 03/07/2025 at 15:29, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group discloses 3.63% ownership in Dalata Hotel Group plc as of 06 March 2025 Irish Takeover Panel The Vanguard Group Ownership Disclosure Financial Disclosure Dalata Hotel Group Plc
PRESS RELEASE published on 03/07/2025 at 15:28, 1 year ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc The Vanguard Group, Inc. files Form 8.3 related to TI Fluid Systems plc disclosing a 3.89% interest in the company's 1p ordinary shares Securities Form 8.3 Disclosure Vanguard Group TI Fluid Systems Plc
PRESS RELEASE published on 03/07/2025 at 15:28, 1 year ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.37% ownership in Direct Line Insurance Group plc as of 06 March 2025. Purchase of 30,376 securities at 2.76 GBP per unit Vanguard Group Ownership Disclosure Financial Disclosure Securities Purchase Direct Line Insurance Group
Published on 03/29/2026 at 12:15, 12 hours 26 minutes ago China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
Published on 03/28/2026 at 01:00, 1 day 22 hours ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 day 22 hours ago Notification of Relevant Change to Significant Shareholder
Published on 03/29/2026 at 17:05, 7 hours 35 minutes ago FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR
Published on 03/28/2026 at 10:05, 1 day 14 hours ago Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 1 day 15 hours ago Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 1 day 21 hours ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 2 days 2 hours ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 18:52, 2 days 5 hours ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 2 days 6 hours ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 2 days 6 hours ago Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 2 days 6 hours ago PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025